Arcutis Biotherapeutics, Inc. ($ARQT)
Filing Information
| Accession Number | 0001628280-26-014328 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 3, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
110,687
Total Value
$92,846.26
P&L
+inf% (+$2,376,470.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Reporting Person's title: EVP, Chief Commercial Officer | Common Stock | โ | Feb 27, 2026 | Grant/Award | 30,000 | $0.00 | $0.00 | 178,865 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Commercial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 3,584 | $25.16 | $90,177.02 | 175,281 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Commercial Officer | Common Stock | โ | Mar 2, 2026 | Sale | 103 | $25.91 | $2,669.23 | 175,178 | Direct | โ | View Details | |
Reporting Person's title: EVP, Chief Commercial Officer | Stock Option (right to buy) | Derivative | Feb 27, 2026 | Grant/Award | 77,000 | $0.00 | $0.00 | 77,000 | Direct | โ | View Details |